{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T10:12:25Z","timestamp":1788862345466,"version":"build-2803163510"},"reference-count":128,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1016\/j.pharmthera.2007.09.007","type":"journal-article","created":{"date-parts":[[2007,11,27]],"date-time":"2007-11-27T15:28:59Z","timestamp":1196177339000},"page":"162-187","source":"Crossref","is-referenced-by-count":52,"title":["The involvement of the \u03bc-opioid receptor in gastrointestinal pathophysiology: Therapeutic opportunities for antagonism at this receptor"],"prefix":"10.1016","volume":"117","author":[{"given":"Diane L.","family":"DeHaven-Hudkins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert N.","family":"DeHaven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick J.","family":"Little","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee M.","family":"Techner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2007.09.007_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmj.322.7295.1154","article-title":"Randomised crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer pain","volume":"322","author":"Allan","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib2","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1213\/00000539-199404000-00015","article-title":"Efficacy of methylnaltrexone versus naloxone for reversal of morphine-induced depression of hypoxic ventilatory response","volume":"78","author":"Amin","year":"1994","journal-title":"Anesth Analg"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib3","unstructured":"Anonymous. (2005). GlaxoSmithKline and Adolor report initial results from Phase 2 studies of Entereg\u2122 (alvimopan). GlaxoSmithKline press release, March 8, 2005."},{"key":"10.1016\/j.pharmthera.2007.09.007_bib4","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1016\/j.lfs.2003.08.047","article-title":"Methylnaltrexone prevents morphine-induced kaolin intake in the rat","volume":"74","author":"Aung","year":"2004","journal-title":"Life Sci"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib5","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1146\/annurev.pa.23.040183.001431","article-title":"Pharmacology of antidiarrheal drugs","volume":"23","author":"Awouters","year":"1983","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib6","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/BF01295711","article-title":"Loperamide. Survey of studies on mechanism of its antidiarrhea activity","volume":"38","author":"Awouters","year":"1993","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib7","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0006-8993(83)90950-2","article-title":"Interaction of the opiate antagonist, naltrexone methyl bromide, with the acetylcholine receptor system of the motor end-plate","volume":"277","author":"Argentieri","year":"1983","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib8","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0306-4522(97)00227-3","article-title":"Cellular localization and distribution of the cloned mu and kappa opioid receptors in rat gastrointestinal tract","volume":"81","author":"Bagnol","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib9","first-page":"91","article-title":"ADL 8-2698 reverses opioid induced delay in colonic transit","volume":"67","author":"Barr","year":"2000","journal-title":"Clin Pharm Ther"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib10","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1053\/cgh.2003.50012","article-title":"Postoperative ileus: etiologies and interventions","volume":"1","author":"Behm","year":"2003","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib11","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1016\/0024-3205(82)90467-2","article-title":"Quaternary narcotic antagonists' relative ability to prevent antinociception and gastrointestinal transit inhibition in morphine-treated rats as an index of peripheral selectivity","volume":"30","author":"Bianchi","year":"1982","journal-title":"Life Sci"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib12","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/0165-6147(85)90188-9","article-title":"The use and misuse of quaternary ammonium opiate antagonists","volume":"6","author":"Brown","year":"1985","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib13","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0028-3908(85)90072-3","article-title":"The use of quaternary narcotic antagonists in opiate research","volume":"24","author":"Brown","year":"1985","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib14","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0028-3908(83)90246-0","article-title":"Reversal of morphine-induced catalepsy in the rat by narcotic antagonists and their quaternary derivatives","volume":"22","author":"Brown","year":"1983","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib15","doi-asserted-by":"crossref","first-page":"G3015","DOI":"10.1016\/S0016-5085(98)82992-2","article-title":"Effect of the opioid antagonist LY 246736 on gastrointestinal transit in human subjects","volume":"114","author":"Callaghan","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib16","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ejphar.2005.08.008","article-title":"Characterization of [3H]alvimopan binding to the cloned human \u03bc-opioid receptor","volume":"520","author":"Cassel","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib17","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/clpt.1992.106","article-title":"Treatment of opioid-induced constipation with oral naloxone: a pilot study","volume":"52","author":"Culpepper-Morgan","year":"1992","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib18","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0014-2999(85)90068-8","article-title":"Autoradiographic localisation of opioid receptors in rat small intestine","volume":"107","author":"Dashwood","year":"1985","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib19","first-page":"165","article-title":"Autoradiographic demonstration of [3H]loperamide binding to opioid receptors in rat and human small intestine","volume":"328","author":"Dashwood","year":"1990","journal-title":"Prog Clin Biol Res"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib20","first-page":"283.13","article-title":"Inhibition of opioid receptor-mediated [35S]GTP\u03b3S binding by ADL 8-2698, a potent opioid receptor antagonist","volume":"26","author":"Daubert","year":"2000","journal-title":"Soc Neurosci Abstr"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib21","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/00001503-200310000-00016","article-title":"Peripherally restricted opioid drugs \u2014 advances and retreats","volume":"16","author":"DeHaven-Hudkins","year":"2003","journal-title":"Curr Opin Anaesthesiol"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib22","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2174\/1381612043453036","article-title":"Peripherally restricted opioid agonists as novel analgesic agents","volume":"10","author":"DeHaven-Hudkins","year":"2004","journal-title":"Curr Pharm Des"},{"issue":"Suppl 2","key":"10.1016\/j.pharmthera.2007.09.007_bib23","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1743-3150.2004.00559.x","article-title":"Clinical perspective on postoperative ileus and the effect of opiates","volume":"16","author":"Delaney","year":"2004","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib24","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1007\/s10350-005-0035-7","article-title":"Phase III trial of alvimopan, a novel, peripherally acting, mu opioid antagonist, for postoperative ileus after major abdominal surgery","volume":"48","author":"Delaney","year":"2005","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib25","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0163-7258(95)02053-5","article-title":"Insights into opioid action in the intestinal tract","volume":"69","author":"De Luca","year":"1996","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib26","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1080\/003655201300191996","article-title":"Antisecretory effect of loperamide in colon epithelial cells by inhibition of basolateral K+ conductance","volume":"36","author":"Epple","year":"2001","journal-title":"Scand J Gastroenterol"},{"issue":"Suppl A","key":"10.1016\/j.pharmthera.2007.09.007_bib27","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S1090-3801(99)90169-6","article-title":"Constipation in cancer patients: prevalence, pathogenesis, and cost-related issues","volume":"3","author":"Fallon","year":"1999","journal-title":"Eur J Pain"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0169-328X(96)00266-5","article-title":"Opioid receptor expression in the rat gastrointestinal tract: a quantitative study with comparison to the brain","volume":"46","author":"Fickel","year":"1997","journal-title":"Mol Brain Res"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib29","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1476-5381.1988.tb11408.x","article-title":"Antinociceptive effects of the novel opioid peptide BW443C compared with classical opiates; peripheral versus central actions","volume":"93","author":"Follefant","year":"1988","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib30","doi-asserted-by":"crossref","first-page":"19S","DOI":"10.1016\/S0002-9610(01)00783-8","article-title":"A review of the potential role of methylnaltrexone in opioid bowel dysfunction","volume":"182","author":"Foss","year":"2001","journal-title":"Am J Surg"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib31","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/j.1552-4604.1993.tb05618.x","article-title":"Dose-related antagonism of the emetic effect of morphine by methylnaltrexone in dogs","volume":"33","author":"Foss","year":"1993","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib32","first-page":"A361","article-title":"Methylnaltrexone does not antagonize the analgesic effect of morphine: a clinical study","volume":"83","author":"Foss","year":"1995","journal-title":"Anesthesiology"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib33","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/009127009703700105","article-title":"Safety and tolerance of methylnaltrexone in healthy humans: a randomized, placebo-controlled, intravenous, ascending-dose, pharmacokinetic study","volume":"37","author":"Foss","year":"1997","journal-title":"J Clin Pharmacol"},{"issue":"3, Suppl 1","key":"10.1016\/j.pharmthera.2007.09.007_bib34","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/j.jpain.2005.01.160","article-title":"Pharmacokinetics (PK) of IV morphine after single and repeat doses of alvimopan, a novel peripherally acting mu-opioid antagonist in humans","volume":"6","author":"Foss","year":"2005","journal-title":"J Pain"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib35","first-page":"1504","article-title":"Pharmacokinetics and safety of alvimopan, a novel, oral, peripherally acting mu-opioid receptor (PAM-OR) antagonist, in patients with renal impairment","volume":"25","author":"Foss","year":"2005","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib36","first-page":"1505","article-title":"Pharmacokinetics of alvimopan, a novel, oral, peripherally acting mu-opioid receptor (PAM-OR) antagonist, and its primary metabolite in the elderly","volume":"25","author":"Foss","year":"2005","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib37","doi-asserted-by":"crossref","first-page":"P74","DOI":"10.1016\/j.clpt.2004.12.175","article-title":"Alvimopan (Entereg), a novel opioid antagonist, achieves active systemic concentrations","volume":"77","author":"Foss","year":"2005","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib38","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.brainres.2006.02.092","article-title":"The selective mu opioid receptor antagonist, alvimopan, improves delayed GI transit of postoperative ileus in rats","volume":"1102","author":"Fukuda","year":"2006","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib39","series-title":"Presentation No. S-281, International Anesthesia Research Society 80th Clinical & Scientific Congress, San Francisco, CA, March 24\u201328.","article-title":"Methylnaltrexone in post-operative bowel dysfunction: results of a double-blind, randomized, placebo-controlled trial in segmental colectomy patients","author":"Gan","year":"2006"},{"issue":"4, Suppl 2","key":"10.1016\/j.pharmthera.2007.09.007_bib40","article-title":"Alvimopan (ALV) shortens whole bowel transit time in adults with chronic constipation (CC)","volume":"126","author":"Garnett","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib41","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1007\/s00384-005-0050-0","article-title":"The duration of postoperative ileus after elective colectomy is correlated to surgical specialization","volume":"21","author":"Gervaz","year":"2006","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib42","first-page":"8","article-title":"Independent central and peripheral mediation of morphine-induced inhibition of gastrointestinal transit in rats","volume":"236","author":"Gmerek","year":"1986","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib43","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/S1542-3565(05)00434-9","article-title":"Effect of alvimopan and codeine on gastrointestinal transit: a randomized controlled study","volume":"3","author":"Gonenne","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"Suppl 2","key":"10.1016\/j.pharmthera.2007.09.007_bib44","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1743-3150.2004.00555.x","article-title":"Preclinical studies of opioids and opioid antagonists on gastrointestinal function","volume":"16","author":"Greenwood-van Meerveld","year":"2004","journal-title":"Neurogastroenterol Motil"},{"issue":"Suppl 2","key":"10.1016\/j.pharmthera.2007.09.007_bib45","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1743-3150.2004.00557.x","article-title":"Peripheral opiate action on afferent fibers supplying the rat intestine","volume":"16","author":"Grundy","year":"2004","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib46","first-page":"51","article-title":"The peripheral analgesic effects of opioids","volume":"2","author":"Hargreaves","year":"1993","journal-title":"APS J"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib47","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1046\/j.1365-2036.2002.01320.x","article-title":"Naloxone treatment for irritable bowel syndrome \u2014 a randomized controlled trial with an oral formulation","volume":"16","author":"Hawkes","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib48","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3109\/00365528709090997","article-title":"Opioids and opioid receptors in peripheral tissues","volume":"130","author":"Hedner","year":"1987","journal-title":"Scand J Gastroenterol Suppl"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib49","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2165\/00003495-197815010-00003","article-title":"Loperamide: a review of its pharmacological properties and therapeutic efficacy in diarrhoea","volume":"15","author":"Heel","year":"1978","journal-title":"Drugs"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib50","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/cne.10606","article-title":"Neurochemically distinct classes of myenteric neurons express the \u03bc-opioid receptor in the guinea pig ileum","volume":"458","author":"Ho","year":"2003","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib51","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1046\/j.1365-2168.2000.01595.x","article-title":"Postoperative ileus: a preventable event","volume":"87","author":"Holte","year":"2000","journal-title":"Br J Surg"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib53","series-title":"American Pain Society 25th Annual Meeting, San Antonio, TX","article-title":"Gastrointestinal adverse events (GIAEs) associated with long-term opioid analgesic therapy in a large, persistent non-cancer pain population [abstract]","author":"Irving","year":"2006"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib54","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.pain.2004.09.019","article-title":"Opioids in chronic non-cancer pain; systematic review of efficacy and safety","volume":"112","author":"Kalso","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib55","first-page":"1505","article-title":"Efficacy of alvimopan, a peripherally acting mu-opioid receptor (PAM-OR) antagonist, and timing of preoperative dosing: pharmacodynamic and pharmacokinetic consideration in patients undergoing open laparotomy","volume":"25","author":"Kariv","year":"2005","journal-title":"Pharmacotheraphy"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib56","doi-asserted-by":"crossref","first-page":"3S","DOI":"10.1016\/S0002-9610(01)00781-4","article-title":"Review of postoperative ileus","volume":"182","author":"Kehlet","year":"2001","journal-title":"Am J Surg"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib57","first-page":"907.3","article-title":"Behavioral profile of ADL 8-2698, a novel GI-restricted \u03bc\u00a0opioid receptor antagonist","volume":"27","author":"Koblish","year":"2001","journal-title":"Soc Neurosci Abstr"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib58","series-title":"Agonist and Antagonist Actions of Narcotic Analgesic Drugs.","article-title":"Morphine receptor in the myenteric plexus of the guinea-pig ileum","author":"Kosterlitz","year":"1972"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib59","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.3109\/00498258909043176","article-title":"Variations in demethylation of N-methylnaltrexone in mice, rats, dogs, and humans","volume":"19","author":"Kotake","year":"1989","journal-title":"Xenobiotica"},{"issue":"8319","key":"10.1016\/j.pharmthera.2007.09.007_bib60","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0140-6736(83)91684-7","article-title":"Naloxone, a specific opioid antagonist, reverses chronic idiopathic constipation","volume":"1","author":"Kreek","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib61","first-page":"1144","article-title":"Effects of short term oral administration of the specific opioid antagonist naloxone on fecal evacuation in geriatric patients","volume":"86","author":"Kreek","year":"1984","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib62","first-page":"121","article-title":"Endogenous and exogenous opioids in the control of gastrointestinal motility and secretion","volume":"40","author":"Kromer","year":"1988","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib63","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2165\/00003495-200363070-00003","article-title":"Opioid-induced bowel dysfunction. Pathophysiology and potential new therapies","volume":"63","author":"Kurz","year":"2003","journal-title":"Drugs"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib64","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s001010050390","article-title":"Oral naloxone antagonizes morphine-induced constipation","volume":"46","author":"Latasch","year":"1997","journal-title":"Anaesthesist"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib65","first-page":"S91","article-title":"Effects of ADL 8-2698, a peripherally restricted mu opioid antagonist, on gut motility in methadone and LAAM-dependent patients with opioid-induced constipation: a dose-ranging study","volume":"63","author":"Liberto","year":"2001","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib66","series-title":"International Narcotics Research Conference, Seattle, WA, July 15\u201320","article-title":"Pharmacological profile of ADL 8-2698, a peripherally restricted opioid receptor antagonist","author":"Little","year":"2000"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib67","first-page":"907.2","article-title":"ADL 8-2698, a GI restricted opioid antagonist, blocks the antisecretory and colorectal transit effects of morphine and loperamide","volume":"27","author":"Little","year":"2001","journal-title":"Soc Neurosci Abstr"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib68","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0885-3924(01)00369-4","article-title":"Low-dose oral naloxone reverses opioid-induced constipation and analgesia","volume":"23","author":"Liu","year":"2002","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib69","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1067\/mcp.2001.112680","article-title":"ADL 8-2698, a trans-3,4-dimethyl-4-(3-hydroxyphenyl) piperidine, prevents gastrointestinal effects of intravenous morphine without affecting analgesia","volume":"69","author":"Liu","year":"2001","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00431767","article-title":"Characterization of the discriminative stimulus effects of centrally administered morphine in the rat","volume":"87","author":"Locke","year":"1985","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib71","first-page":"1706","article-title":"Effects of novel \u03bc-opioid antagonists on gastrointestinal (GI) transit in mice","volume":"25","author":"Long","year":"1999","journal-title":"Soc Neurosci Abstr"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib72","series-title":"American College of Surgeons 92nd Annual Clinical Congress; October 8\u201312, 2006; Chicago, IL","article-title":"Accelerated gastrointestinal recovery and reduced length of stay following modified preoperative dose timing with alvimopan: results of a large, randomized, placebo-controlled study in partial bowel resection","author":"Ludwig","year":"2006"},{"issue":"Suppl. 1","key":"10.1016\/j.pharmthera.2007.09.007_bib73","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/10732748040110S302","article-title":"Assessing and managing opiate-induced constipation in adults with cancer","volume":"11","author":"McMillan","year":"2004","journal-title":"Cancer Control"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib74","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0304-3959(99)00185-2","article-title":"Oral naloxone reverses opioid-induced constipation","volume":"84","author":"Meissner","year":"2000","journal-title":"Pain"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib75","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0031-9384(85)90345-2","article-title":"Quaternary naltrexone reverses morphine-induced behaviors","volume":"35","author":"Mickley","year":"1985","journal-title":"Physiol Behav"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib76","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.2042-7158.1987.tb06254.x","article-title":"Intravenous kinetics and metabolism of [15,16-3H]naltrexonium methiodide in the rat","volume":"39","author":"Misra","year":"1987","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib77","first-page":"127","article-title":"Evaluation of methylnaltrexone for the reduction of postoperative vomiting and nausea incidences","volume":"46","author":"Moerman","year":"1995","journal-title":"Acta Anaesthesiol Belg"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib78","series-title":"American Pain Society 25th Annual Meeting, San Antonio, TX","article-title":"Efficacy of alvimopan, a peripheral opioid receptor antagonist, for the management of gastrointestinal adverse events (GIAEs) associated with opioid use: assessment using the PAC-SYM questionnaire. [abstract]","author":"Morlion","year":"2006"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib79","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1097\/00000542-199710000-00008","article-title":"Opioid-induced delay in gastric emptying: a peripheral mechanism in humans","volume":"87","author":"Murphy","year":"1997","journal-title":"Anesthesiology"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib80","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ddr.430010102","article-title":"Pharmacology and antidiarrheal effect of loperamide","volume":"1","author":"Niemegeers","year":"1981","journal-title":"Drug Dev Res"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib81","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/S0016-5085(86)80002-6","article-title":"Autoradiographic localization of \u03bc- and \u03b4-type opioid receptors in the gastrointestinal tract of the rat and guinea pig","volume":"91","author":"Nishimura","year":"1986","journal-title":"Gastroenterology"},{"issue":"5A Suppl","key":"10.1016\/j.pharmthera.2007.09.007_bib82","doi-asserted-by":"crossref","first-page":"11S","DOI":"10.1016\/S0002-9610(01)00782-6","article-title":"Incidence, prevalence, and management of opioid bowel dysfunction","volume":"182","author":"Pappagallo","year":"2001","journal-title":"Am J Surg"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib83","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.neuroscience.2003.08.052","article-title":"Abdominal surgery induces \u03bc-opioid receptor endocytosis in enteric neurons of the guinea-pig ileum","volume":"123","author":"Patierno","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib84","series-title":"Presented at the 10th World Congress on Pain; August 17\u201322, 2002; San Diego, CA. 2002 Abstracts Viewer\/Itinerary Planner","first-page":"197","article-title":"A forced titration, dose ranging study of alvimopan for the reversal of opioid-induced bowel dysfunction","author":"Paulson","year":"2002"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib85","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jpain.2004.12.001","article-title":"Alvimopan: an oral, peripherally acting, \u03bc-opioid receptor antagonist for the treatment of opioid-induced bowel dysfunction \u2014 a 21-day treatment-randomized clinical trial","volume":"6","author":"Paulson","year":"2005","journal-title":"J Pain"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib86","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1124\/mol.60.5.894","article-title":"Inflammation enhances \u03bc-opioid receptor transcription and expression in mice intestine","volume":"60","author":"Pol","year":"2001","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib87","doi-asserted-by":"crossref","first-page":"PL-219","DOI":"10.1016\/0024-3205(91)90297-O","article-title":"Opiate binding sites in mucosa of pig small intestine","volume":"49","author":"Quito","year":"1991","journal-title":"Life Sci"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib88","series-title":"Presented at the 10th World Congress on Pain; August 17\u201322, 2002; San Diego, CA. Abstracts Viewer \/ Itinerary Planner","first-page":"550","article-title":"Use of alvimopan, a peripherally restricted \u03bc-opioid antagonist, to speed gastrointestinal transit in patients with opioid induced bowel dysfunction","author":"Rauck","year":"2002"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib89","first-page":"628","article-title":"Loperamide: blockade of calcium channels as a mechanism for antidiarrheal effects","volume":"231","author":"Reynolds","year":"1984","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib90","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/0140-6736(91)91156-O","article-title":"Oral naloxone in opioid-associated constipation","volume":"338","author":"Robinson","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib91","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0014-2999(82)90026-7","article-title":"Antagonism of gut, but not central effects of morphine with quaternary narcotic antagonists","volume":"78","author":"Russell","year":"1982","journal-title":"Eur J Pharmacol"},{"issue":"Suppl. 2","key":"10.1016\/j.pharmthera.2007.09.007_bib92","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1743-3150.2004.00556.x","article-title":"The role of endogenous opioids in the control of gastrointestinal motility: predictions from in vitro modeling","volume":"16","author":"Sanger","year":"2004","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib93","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1172\/JCI118699","article-title":"P-Glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs","volume":"97","author":"Schinkel","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib94","doi-asserted-by":"crossref","first-page":"27S","DOI":"10.1016\/S0002-9610(01)00784-X","article-title":"Alvimopan (ADL 8-2698) is a novel peripheral opioid antagonist","volume":"182","author":"Schmidt","year":"2001","journal-title":"Am J Surg"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib95","doi-asserted-by":"crossref","first-page":"P49","DOI":"10.1016\/j.clpt.2004.12.080","article-title":"Alvimopan pharmacokinetics (PK) & pharmacodynamics (PD) in patients with chronic constipation","volume":"77","author":"Schmith","year":"2005","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib96","doi-asserted-by":"crossref","first-page":"A452","DOI":"10.1097\/00000542-200209002-00452","article-title":"Evaluation of a new \u03bc-opioid antagonist for the management of postoperative ileus: additional Phase II study results","volume":"96","author":"Sharma","year":"2002","journal-title":"Anesthesiology"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib97","series-title":"11th World Congress on Pain; August 22, 2005; Sydney, Australia. Abstracts Viewer\/Itinerary Planner.","article-title":"A phase III double-blind placebo-controlled trial of methylnaltrexone (MNTX) for opioid-induced constipation (OIC) in advanced medical illness (AMI)","author":"Slatkin","year":"2005"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib98","first-page":"1269","article-title":"Peripheral opioid receptors mediating antinociception in inflammation. Evidence for involvement of mu, delta and kappa receptors","volume":"248","author":"Stein","year":"1989","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib99","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/nm908","article-title":"Attacking pain at its source: new perspectives on opioids","volume":"9","author":"Stein","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib100","doi-asserted-by":"crossref","first-page":"G8","DOI":"10.1152\/ajpgi.2001.281.1.G8","article-title":"Receptors and transmission in the brain-gut axis: potential for novel therapies III. \u03bc-Opioid receptors in the enteric nervous system","volume":"281","author":"Sternini","year":"2001","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"Suppl. 2","key":"10.1016\/j.pharmthera.2007.09.007_bib101","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1743-3150.2004.00553.x","article-title":"The opioid system in the gastrointestinal tract","volume":"16","author":"Sternini","year":"2004","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib102","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1177\/026921639601000208","article-title":"An investigation of the ability of oral naloxone to correct opioid-related constipation in patients with advanced cancer","volume":"10","author":"Sykes","year":"1996","journal-title":"Palliat Med"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib103","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1056\/NEJMoa010564","article-title":"Selective postoperative inhibition of gastrointestinal opioid receptors","volume":"345","author":"Taguchi","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib104","series-title":"American Pain Society 25th Annual Meeting, San Antonio, TX","article-title":"Effect of alvimopan, a peripheral opioid receptor antagonist, on health-related quality of life (HRQOL) in patients who develop gastrointestinal adverse events (GIAEs) while taking opioids for persistent non-cancer pain [abstract]","author":"Tark","year":"2006"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib105","series-title":"American Society of Clinical Oncology Annual Meeting, Abstract No. 2933. Chicago, IL, May 30\u2013June 3. Abstracts Viewer\/Itinerary Planner. Online","article-title":"A phase II randomized dose-finding trial of methylnaltrexone for the relief of opioid-induced constipation in hospice patients","author":"Thomas","year":"2003"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib106","series-title":"2005 American Society of Clinical Oncology Annual Meeting, Abstract No. 8003. Orlando, FL, May 13\u201317. Abstracts Viewer\/Itinerary Planner. Online","article-title":"A phase III double-blind placebo-controlled trial of methylnaltrexone (MNTX) for opioid-induced constipation (OIC) in advanced medical illness (AMI)","author":"Thomas","year":"2005"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib107","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1016\/0024-3205(83)90325-9","article-title":"Receptor binding, antagonist, and withdrawal precipitating properties of opiate antagonists","volume":"32","author":"Valentino","year":"1983","journal-title":"Life Sci"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib108","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s00464-005-0104-y","article-title":"Alvimopan, a novel peripherally acting mu-opioid receptor antagonist, compared with placebo in postoperative ileus after major abdominal surgery","volume":"20","author":"Viscusi","year":"2006","journal-title":"Surg Endosc"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib109","series-title":"American Pain Society 25th Annual Meeting, San Antonio, TX","article-title":"Alvimopan, a novel peripherally acting mu-opioid receptor antagonist, does not affect opioid-based, centrally-mediated analgesia follwing surgery. [abstract]","author":"Viscusi","year":"2006"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib110","series-title":"American Pain Society 25th Annual Meeting, San Antonio, TX","article-title":"A randomized, double-blind, placebo-controlled, multicenter phase IIb study to evaluate the efficacy and safety of multiple alvimopan dosage regimens for the treatment of gastrointestinal adverse events (GIAEs) associated with opioid use in subjects. [abstract]","author":"Webster","year":"2006"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib111","first-page":"325","article-title":"Evidence for anticholinergic effects of naltrexone methylbromide","volume":"4","author":"Willette","year":"1983","journal-title":"Res Commun Subst Abuse"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib112","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1097\/01.sla.0000141158.27977.66","article-title":"Alvimopan, a novel, peripherally acting \u03bc-opioid antagonist. Results of a multicenter, randomized, double-blind, placebo-controlled, Phase III trial of major abdominal surgery and postoperative ileus","volume":"240","author":"Wolff","year":"2004","journal-title":"Ann Surg"},{"issue":"Suppl. 2","key":"10.1016\/j.pharmthera.2007.09.007_bib114","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1743-3150.2004.00554.x","article-title":"Function of opioids in the enteric nervous system","volume":"16","author":"Wood","year":"2004","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib113","first-page":"57","article-title":"Postoperative ileus: dogma versus data from bench to bedside","volume":"12","author":"Woods","year":"2000","journal-title":"Perspect Colon Rectal Surg"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib115","first-page":"111","article-title":"Clinical status of methylnaltrexone, a new agent to prevent and manage opioid-induced side effects","volume":"2","author":"Yuan","year":"2004","journal-title":"J Support Oncol"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib116","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/1098-2299(200006)50:2<133::AID-DDR1>3.0.CO;2-8","article-title":"Methylnaltrexone: investigation of clinical applications","volume":"50","author":"Yuan","year":"2000","journal-title":"Drug Dev Res"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib117","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1001\/jama.284.11.1383","article-title":"Oral methylnaltrexone for opioid-induced constipation","volume":"284","author":"Yuan","year":"2000","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib118","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0014-2999(95)00018-G","article-title":"Effects of methylnaltrexone on morphine-induced inhibition of contraction in isolated guinea-pig ileum and human intestine","volume":"276","author":"Yuan","year":"1995","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib119","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0009-9236(96)90117-4","article-title":"Methylnaltrexone prevents morphine-induced delay in oral\u2013cecal transit time without affecting analgesia: a double-blind randomized placebo-controlled trial","volume":"59","author":"Yuan","year":"1996","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib120","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0009-9236(97)90197-1","article-title":"The safety and efficacy of oral methylnaltrexone in preventing morphine-induced delay in oral\u2013cecal transit time","volume":"61","author":"Yuan","year":"1997","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib121","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0376-8716(98)00087-8","article-title":"Efficacy of orally administered methylnaltrexone in decreasing subjective effects after intravenous morphine","volume":"52","author":"Yuan","year":"1998","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib122","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0304-3959(99)00162-1","article-title":"Effect of intravenous methylnaltrexone in opioid-induced gut motility and transit time changes in subjects receiving chronic methadone therapy: a pilot study","volume":"83","author":"Yuan","year":"1999","journal-title":"Pain"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib123","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1067\/mcp.2000.105037","article-title":"Effects of enteric-coated methylnaltrexone in preventing opioid-induced delay in oral\u2013cecal transit time","volume":"67","author":"Yuan","year":"2000","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib124","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1001\/jama.283.3.367","article-title":"Methylnaltrexone for reversal of constipation due to chronic methadone use: a randomized controlled trial","volume":"283","author":"Yuan","year":"2000","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib125","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1124\/jpet.300.1.118","article-title":"Effects of subcutaneous methylnaltrexone on morphine-induced peripherally mediated side effects: a double-blind randomized placebo-controlled trial","volume":"300","author":"Yuan","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib126","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1177\/0091270004273491","article-title":"Tolerability, gut effects, and pharmacokinetics of methylnaltrexone following repeated intravenous administration in humans","volume":"45","author":"Yuan","year":"2005","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib127","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1021\/jm00041a003","article-title":"Discovery of a potent, peripherally selective trans-3,4-dimethyl-4-(3-hydroxyphenyl)piperidine opioid antagonist for the treatment of gastrointestinal motility disorders","volume":"37","author":"Zimmerman","year":"1994","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib128","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1358\/dof.1994.019.12.276933","article-title":"LY246736 dihydrate","volume":"19","author":"Zimmerman","year":"1994","journal-title":"Drugs Future"},{"key":"10.1016\/j.pharmthera.2007.09.007_bib129","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1124\/mol.64.2.202","article-title":"Painful inflammation-induced increase in mu-opioid receptor binding and G-protein coupling in primary afferent neurons","volume":"64","author":"Zollner","year":"2003","journal-title":"Mol Pharmacol"}],"container-title":["Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725807002045?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725807002045?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,29]],"date-time":"2021-08-29T08:07:29Z","timestamp":1630224449000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725807002045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":128,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S0163725807002045"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2007.09.007","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]}}}